NEW DELHIRanbaxy Laboratories Ltd won approval Thursday to produce a generic version of Novartis AGs blockbuster bloodpressure drug Diovan improving the Indian companys prospects after years of regulatory problems The Gurgaonbased company was supposed to begin Diovan production in late  but the Indian plant that was to produce the drug was barred from exporting to the US by the Food and Drug Administration Now
  